Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20  mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use

Page 2, column 2, section “What is the clinical efficacy of OLM/AMT/HCT 20 mg/5 mg/12.5 mg?”, paragraph 1, lines 5–8: The following text, which previously read.
Source: Drugs and Therapy Perspectives - Category: Drugs & Pharmacology Source Type: research